Flagship explainer
How RIGEL PHARMACEUTICALS INC makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $294M | 100% |
| |
| Cost of revenue | $19.6M | 7% |
|
| $275M | 93% |
| |
| $125M | 43% |
| |
| Income before tax | $122M | 41% |
|
| Income tax | −$245M | −83% |
|
| $367M | 125% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001034842-26-000015